Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Arrhythmias
This study suggests that GLP-1 RAs use among obese patients was associated with lower risk of arrhythmias at both 1-year and 3-year follow-ups.
Authors
- Vamsi Garimella
- Aman Goyal (ORCID: https://orcid.org/0000-0001-8062-5657)
- Juveriya Yasmeen
- Roopeessh Vempati (ORCID: https://orcid.org/0000-0001-5966-909X)
- Muhammad Touqeer Hanif (ORCID: https://orcid.org/0000-0002-7360-9744)
- Yusra Nasir
- Jishanth Mattumpuram (ORCID: https://orcid.org/0000-0002-6359-3435)
- Novonil Deb (ORCID: https://orcid.org/0000-0002-9005-8358)
- Vikash Jaiswal (ORCID: https://orcid.org/0000-0002-2021-1660)
- Yusra Mashkoor (ORCID: https://orcid.org/0000-0001-7943-7106)
- Abhigan Babu Shrestha (ORCID: https://orcid.org/0000-0002-0681-3825)
- Andrew M. Weinberg
- Kripa Rajak
Institutions
- Cleveland Clinic (US)
- Patan Academy of Health Sciences (NP)
- University of Louisville (US)
- University of Miami (US)
- SUNY Upstate Medical University (US)
- Dow University of Health Sciences (PK)
- North Bengal Medical College and Hospital (IN)
- Trinity Health Oakland Hospital (US)
- Saint Joseph Hospital (US)
- University of Oklahoma Health Sciences Center (US)
- Jawaharlal Nehru Technological University Anantapur (IN)
- University of Missouri (US)
Publication Details
- Journal
- Journal of Arrhythmia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/joa3.70242
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00